Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al
(Q46669969)
scientific article published on 25 August 2005
scientific article published on 25 August 2005
Language: